Reciprocal cross-talk between Nod2 and TAK1 signaling pathways

被引:64
作者
Chen, CM [1 ]
Gong, YS [1 ]
Zhang, M [1 ]
Chen, JJ [1 ]
机构
[1] Univ Michigan, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA
关键词
D O I
10.1074/jbc.M400682200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutations in the leucine-rich repeat (LRR) domain of Nod2 have been implicated in the pathogenesis of Crohn's disease, yet the function of Nod2 and regulation of the Nod2 pathway remain unclear. In this study, we determined that mitogen-activated protein kinase kinase transforming growth factor (TGF)-beta-activated kinase 1 (TAK1) interacts with Nod2 and is required for Nod2-mediated NF-kappaB activation. The dominant negative form of TAK1 abolished muramyl dipeptide-induced NF-kappaB activation in Nod2-expressing cells. Nod2, acting in a reciprocal manner, inhibited TAK1-induced NF-kappaB activation in RICK-deficient embryonic fibroblasts. Nod2 appears to interact with TAK1 through its LRR region to exert its inhibitory effect on TAK1-induced NF-kappaB activation. Further, wild-type LRR more effectively suppressed NF-kappaB activation induced by TAK1 than LRR with a 3020insC mutation. Considered together, these findings demonstrate a critical role for TAK1 in Nod2-mediated innate immune responses and reveal a novel function for Nod2 in the regulation of the TAK1 signaling pathway.
引用
收藏
页码:25876 / 25882
页数:7
相关论文
共 34 条
[1]   NF-kappa B: Ten years after [J].
Baeuerle, PA ;
Baltimore, D .
CELL, 1996, 87 (01) :13-20
[2]   INTERLEUKIN-8, A CHEMOTACTIC AND INFLAMMATORY CYTOKINE [J].
BAGGIOLINI, M ;
CLARKLEWIS, I .
FEBS LETTERS, 1992, 307 (01) :97-101
[3]   The NF-kappa B and I kappa B proteins: New discoveries and insights [J].
Baldwin, AS .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :649-683
[4]   Autoimmunity and apoptosis: The Crohn's connection [J].
Beutler, B .
IMMUNITY, 2001, 15 (01) :5-14
[5]   Involvement of receptor-interacting protein 2 in innate and adaptive immune responses [J].
Chin, AI ;
Dempsey, PW ;
Bruhn, K ;
Miller, JF ;
Xu, Y ;
Cheng, GH .
NATURE, 2002, 416 (6877) :190-194
[6]   Genes, microbes, and T cells - New therapeutic targets in Crohn's disease [J].
Elson, CO .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (08) :614-616
[7]   ULCERATIVE-COLITIS AND CROHNS-DISEASE [J].
FERGUSON, A .
BRITISH MEDICAL JOURNAL, 1994, 309 (6951) :355-356
[8]   Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection [J].
Girardin, SE ;
Boneca, IG ;
Viala, J ;
Chamaillard, M ;
Labigne, A ;
Thomas, G ;
Philpott, DJ ;
Sansonetti, PJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (11) :8869-8872
[9]   Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-κB activation [J].
Gutierrez, O ;
Pipaon, C ;
Inohara, N ;
Fontalba, A ;
Ogura, Y ;
Prosper, F ;
Nuñez, G ;
Fernandez-Luna, JL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (44) :41701-41705
[10]   Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations [J].
Hampe, J ;
Cuthbert, A ;
Croucher, PJP ;
Mirza, MM ;
Mascheretti, S ;
Fisher, S ;
Frenzel, H ;
King, K ;
Hasselmeyer, A ;
MacPherson, AJS ;
Bridger, S ;
van Deventer, S ;
Forbes, A ;
Nikolaus, S ;
Lennard-Jones, JE ;
Foelsch, UR ;
Krawczak, M ;
Lewis, C ;
Schreiber, S ;
Mathew, CG .
LANCET, 2001, 357 (9272) :1925-1928